WHO ICTRP trial

The effect of administration of midazolam and ketorolac in comparison with…

IRCT20220516054869N5 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting

Key facts

Trial ID IRCT20220516054869N5
Public title The effect of administration of midazolam and ketorolac in comparison with administration of morphine and ketorolac on pain relief in patients with renal colic
Scientific title Investigating the effect of prescribing midazolam and ketorolac in comparison with prescribing morphine and ketorolac on the pain relief of renal colic patients referred to the emergency department of Khatam al-Anbia in Zahedan in 2025
Primary sponsor Zahedan University of Medical Sciences
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Not Recruiting
Study type interventional
Phase 3
Countries Iran (Islamic Republic of)
Conditions Pain management of renal colic patients. Acute pain, not elsewhere classified;G89.1
Interventions Intervention 1: Intervention group: In the first group, 30 mg of intravenous ketorolac will be administered within one minute and 5 mg of intravenous morphine (in a volume of 5 cc) will be prescribed within five minutes. Intervention 2…
Registration date Nov 10, 2024
Target size 200
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations